2m 2m 2m 2m 2m 2m 2m
PTC Therapeutics (PTCT)
NASDAQ
$70.22+$0.40 (+0.58%)
Price as of Aug 21, 2026 7:32 PM EDT- $5.8BMarket Cap
- 38.07%1-Year Change
- BiotechnologyIndustry
PTC Therapeutics (PTCT)
$70.22+$0.40 (+0.58%)
PTCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $69.82 | ||
Change | -$0.70 (-0.99%) | ||
Open | $70.54 | ||
High | $71.36 | ||
Low | $69.79 | ||
Previous Close | $70.52 | ||
Volume | 674,737 | ||
30-Day Average Volume | 1,167,611 | ||
1-Week Change | -2.62% | ||
1-Month Change | -11.06% | ||
1-Year Change | 38.07% | ||
3-Year Change | 75.43% | ||
5-Year Change | 82.77% | ||
Fundamentals | |||
Shares Outstanding | 83.5M | ||
Total Assets | $3.3B | ||
Market Cap | $5.8B | ||
Enterprise Value | $5.4B | ||
Period: QTR TTM FY | |||
Revenue | $238.8M | ||
Net Income | $83.5M | ||
Free Cash Flow | $126.9M | ||
EBIT | $146.0M | ||
EBITDA | $161.9M | ||
Net Working Capital | $1.8B | ||
EPS | $0.92 | ||
Enterprise Value/EBITDA | 33 | ||
Enterprise Value/Revenue | 22 | ||
P/B | -35 | ||
P/E | 76 | ||
PEG | 0 | ||
Price/Free Cash Flow | 46 | ||
Price/Operating Cash Flow | 45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue